Table 1.
Correlation Between aPKCɩ, CD68, CD80, CD206, NF-κB, and Clinicopathologic Characteristics in 70 CCA Patients
Group | n | aPKCɩ | P | CD68 | P | CD80 | P | CD206 | P | NF-κB | P | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Low | High | Low | High | Low | High | Low | High | Low | High | |||||||
Age (years) | ||||||||||||||||
≤ 60 | 37 | 19 | 18 | 0.208 | 12 | 25 | 0.449 | 18 | 19 | 0.602 | 19 | 18 | 0.622 | 19 | 18 | 0.316 |
> 60 | 33 | 12 | 21 | 8 | 25 | 14 | 19 | 15 | 18 | 13 | 20 | |||||
Gender | ||||||||||||||||
Male | 36 | 17 | 19 | 0.611 | 10 | 26 | 0.880 | 12 | 24 | 0.089 | 16 | 20 | 0.477 | 17 | 19 | 0.794 |
Female | 34 | 14 | 20 | 10 | 24 | 20 | 14 | 18 | 16 | 15 | 19 | |||||
Lymphoid nodal status | ||||||||||||||||
No | 45 | 24 | 21 | 0.041 | 16 | 29 | 0.044 | 20 | 25 | 0.866 | 25 | 18 | 0.043 | 28 | 15 | <0.001 |
Yes | 25 | 7 | 18 | 4 | 21 | 12 | 13 | 9 | 18 | 4 | 23 | |||||
TNM staging | ||||||||||||||||
I-II | 33 | 20 | 13 | 0.009 | 14 | 19 | 0.015 | 16 | 17 | 0.819 | 24 | 9 | <0.001 | 25 | 8 | <0.001 |
III-IV | 37 | 11 | 26 | 6 | 31 | 16 | 19 | 11 | 26 | 7 | 30 | |||||
Differentiation | ||||||||||||||||
Well | 27 | 16 | 11 | 0.046 | 9 | 18 | 0.485 | 11 | 16 | 0.508 | 17 | 10 | 0.044 | 16 | 11 | 0.071 |
Moderate/Poorly | 43 | 15 | 28 | 11 | 32 | 21 | 22 | 17 | 26 | 16 | 27 |